Stay updated on Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the page, indicating a newer platform revision tag. This change does not modify study details, eligibility criteria, or results on the page.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page’s footer release/revision label has been updated from v3.5.2 to v3.5.3, indicating a site/version maintenance update rather than a change to the clinical trial study details.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a new Resources entry: Cutaneous neuroendocrine carcinoma with Genetic and Rare Diseases Information Center.SummaryDifference0.1%

- Check77 days agoChange Detected- Revision labels updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.